To assess the tumor growth inhibitory (TGI) efficacy of plant-produced Atezolizumab, a BALB/c-hPD-1/hPD-L1/hCTLA-4 mouse model was subcutaneously transplanted with mouse colon tumor CT26 cells expressing hPD-L1. The gene discussed is CD274; the disease is neoplasm.